Literature DB >> 18472219

Productivity and health effects of anaplasmosis and babesiosis on Bos indicus cattle and their crosses, and the effects of differing intensity of tick control in Australia.

N N Jonsson1, R E Bock, W K Jorgensen.   

Abstract

Tick fever is an important disease of cattle where Rhipicephalus (Boophilus) microplus acts as a vector for the three causal organisms Babesia bovis, Babesia bigemina and Anaplasma marginale. Bos indicus cattle and their crosses are more resistant to the clinical effects of infection with B. bovis and B. bigemina than are Bos taurus cattle. Resistance is not complete, however, and herds of B. indicus-cross cattle are still at risk of babesiosis in environments where exposure to B. bovis is light in most years but occasionally high. The susceptibility of B. indicus cattle and their crosses to infection with A. marginale is similar to that of B. taurus cattle. In herds of B. indicus cattle and their crosses the infection rate of Babesia spp. and A. marginale is lowered because fewer ticks are likely to attach per day due to reduced numbers of ticks in the field (long-term effect on population, arising from high host resistance) and because a smaller proportion of ticks that do develop to feed on infected cattle will in turn be infected (due to lower parasitaemia). As a consequence, herds of B. indicus cattle are less likely than herds of B. taurus cattle to have high levels of population immunity to babesiosis or anaplasmosis. The effects of acaricide application on the probability of clinical disease due to anaplasmosis and babesiosis are unpredictable and dependent on the prevalence of infection in ticks and in cattle at the time of application. Attempting to manipulate population immunity through the toleration of specific threshold numbers of ticks with the aim of controlling tick fever is not reliable and the justification for acaricide application should be for the control of ticks rather than for tick fever. Vaccination of B. indicus cattle and their crosses is advisable in all areas where ticks exist, although vaccination against B. bigemina is probably not essential in pure B. indicus animals.

Entities:  

Mesh:

Year:  2008        PMID: 18472219     DOI: 10.1016/j.vetpar.2008.03.022

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  28 in total

1.  Comparison of iatrogenic transmission of Anaplasma marginale in Holstein steers via needle and needle-free injection techniques.

Authors:  James B Reinbold; Johann F Coetzee; Larry C Hollis; Jason S Nickell; Casey M Riegel; Julia A Christopher; Roman R Ganta
Journal:  Am J Vet Res       Date:  2010-10       Impact factor: 1.156

2.  One Health approach to identify research needs in bovine and human babesioses: workshop report.

Authors:  Adalberto A Pérez de León; Daniel A Strickman; Donald P Knowles; Durland Fish; Eileen Thacker; José de la Fuente; Peter J Krause; Stephen K Wikel; Ryan S Miller; Gale G Wagner; Consuelo Almazán; Robert Hillman; Matthew T Messenger; Paul O Ugstad; Roberta A Duhaime; Pete D Teel; Alfonso Ortega-Santos; David G Hewitt; Edwin J Bowers; Stephen J Bent; Matt H Cochran; Terry F McElwain; Glen A Scoles; Carlos E Suarez; Ronald Davey; Jeanne M Howell Freeman; Kimberly Lohmeyer; Andrew Y Li; Felix D Guerrero; Diane M Kammlah; Pamela Phillips; Joe M Pound
Journal:  Parasit Vectors       Date:  2010-04-08       Impact factor: 3.876

3.  Rhipicephalus microplus salivary gland molecules induce differential CD86 expression in murine macrophages.

Authors:  Danett K Brake; Stephen K Wikel; Jason P Tidwell; Adalberto A Pérez de León
Journal:  Parasit Vectors       Date:  2010-11-05       Impact factor: 3.876

4.  In vitro activities of plant extracts from the Brazilian Cerrado and Pantanal against Rhipicephalus (Boophilus) microplus (Acari: Ixodidae).

Authors:  Carolina da Silva Barbosa; Ligia Miranda Ferreira Borges; José Nicácio; Reginaldo Dias Alves; Carlos Henrique Miguita; Ivana Maria Póvoa Violante; Lidilhone Hamerski; Walmir Silva Garcez; Fernanda Rodrigues Garcez
Journal:  Exp Appl Acarol       Date:  2013-01-24       Impact factor: 2.132

5.  ABC transporters as a multidrug detoxification mechanism in Rhipicephalus (Boophilus) microplus.

Authors:  Paula C Pohl; Guilherme M Klafke; José Reck Júnior; João Ricardo Martins; Itabajara da Silva Vaz; Aoi Masuda
Journal:  Parasitol Res       Date:  2012-08-29       Impact factor: 2.289

6.  Seroprevalence estimation and management factors associated with high herd seropositivity for Babesia bovis in commercial dairy farms of Puerto Rico.

Authors:  J H Urdaz-Rodríguez; G T Fosgate; S D Waghela; A R Alleman; D O Rae; G A Donovan; P Melendez
Journal:  Trop Anim Health Prod       Date:  2009-04-03       Impact factor: 1.559

7.  Causes of death in beef cattle in southern Brazil.

Authors:  Franciéli A Molossi; Bianca S de Cecco; Camila B Pohl; Rogério B Borges; Luciana Sonne; Saulo P Pavarini; David Driemeier
Journal:  J Vet Diagn Invest       Date:  2021-04-09       Impact factor: 1.279

8.  Characterization of proteinases from the midgut of Rhipicephalus (Boophilus) microplus involved in the generation of antimicrobial peptides.

Authors:  Carlos E Cruz; Andréa C Fogaça; Ernesto S Nakayasu; Cláudia B Angeli; Rodrigo Belmonte; Igor C Almeida; Antônio Miranda; Maria Terêsa M Miranda; Aparecida S Tanaka; Glória R Braz; Charles S Craik; Eric Schneider; Conor R Caffrey; Sirlei Daffre
Journal:  Parasit Vectors       Date:  2010-07-27       Impact factor: 3.876

9.  Development of a multiplex PCR assay for simultaneous detection of Theileria annulata, Babesia bovis and Anaplasma marginale in cattle.

Authors:  Huseyin B Bilgiç; Tülin Karagenç; Martin Simuunza; Brian Shiels; Andy Tait; Hasan Eren; William Weir
Journal:  Exp Parasitol       Date:  2012-11-24       Impact factor: 2.011

10.  Inhibition of enzyme activity of Rhipicephalus (Boophilus) microplus triosephosphate isomerase and BME26 cell growth by monoclonal antibodies.

Authors:  Luiz Saramago; Mariana Franceschi; Carlos Logullo; Aoi Masuda; Itabajara da Silva Vaz; Sandra Estrazulas Farias; Jorge Moraes
Journal:  Int J Mol Sci       Date:  2012-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.